These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30098669)

  • 1. Effect of Interferon-Free Regimens on Disparities in Hepatitis C Treatment of US Veterans.
    Barnett PG; Joyce VR; Lo J; Gidwani-Marszowski R; Goldhaber-Fiebert JD; Desai M; Asch SM; Holodniy M; Owens DK
    Value Health; 2018 Aug; 21(8):921-930. PubMed ID: 30098669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.
    Janjua NZ; Islam N; Wong J; Yoshida EM; Ramji A; Samji H; Butt ZA; Chong M; Cook D; Alvarez M; Darvishian M; Tyndall M; Krajden M
    J Viral Hepat; 2017 Aug; 24(8):624-630. PubMed ID: 28130810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans.
    Goulet JL; Fultz SL; McGinnis KA; Justice AC
    AIDS; 2005 Oct; 19 Suppl 3():S99-105. PubMed ID: 16251836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate and predictors of treatment prescription for hepatitis C.
    Butt AA; Justice AC; Skanderson M; Rigsby MO; Good CB; Kwoh CK
    Gut; 2007 Mar; 56(3):385-9. PubMed ID: 17005764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.
    Vespasiani-Gentilucci U; Galati G; Gallo P; De Vincentis A; Riva E; Picardi A
    World J Gastroenterol; 2015 Jun; 21(24):7412-26. PubMed ID: 26139987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response of US veterans to treatment for the hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    Hepatology; 2007 Jul; 46(1):37-47. PubMed ID: 17567830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample.
    Rogal SS; Yakovchenko V; Waltz TJ; Powell BJ; Kirchner JE; Proctor EK; Gonzalez R; Park A; Ross D; Morgan TR; Chartier M; Chinman MJ
    Implement Sci; 2017 May; 12(1):60. PubMed ID: 28494811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
    Butt AA; Yan P; Shaikh OS; Chung RT; Sherman KE;
    Liver Int; 2016 Sep; 36(9):1275-83. PubMed ID: 26928927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.
    Hawks L; Wang EA; Butt AA; Crystal S; Keith McInnes D; Re VL; Cartwright EJ; Puglisi LB; Haque LYK; Lim JK; Justice AC; McGinnis KA
    Am J Public Health; 2023 Feb; 113(2):162-165. PubMed ID: 36480765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry.
    McCombs J; Matsuda T; Tonnu-Mihara I; Saab S; Hines P; L'italien G; Juday T; Yuan Y
    JAMA Intern Med; 2014 Feb; 174(2):204-12. PubMed ID: 24193887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in hepatitis C testing in U.S. veterans born 1945-1965.
    Sarkar S; Esserman DA; Skanderson M; Levin FL; Justice AC; Lim JK
    J Hepatol; 2016 Aug; 65(2):259-65. PubMed ID: 27130843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender disparities in Veterans Health Administration care: importance of accounting for veteran status.
    Frayne SM; Yano EM; Nguyen VQ; Yu W; Ananth L; Chiu VY; Phibbs CS
    Med Care; 2008 May; 46(5):549-53. PubMed ID: 18438204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatitis C virus infection in American veterans.
    Cheung RC
    Am J Gastroenterol; 2000 Mar; 95(3):740-7. PubMed ID: 10710068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Maier MM; Zhou XH; Chapko M; Leipertz SL; Wang X; Beste LA
    Dig Dis Sci; 2018 Jun; 63(6):1454-1462. PubMed ID: 29453610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders.
    Huckans MS; Blackwell AD; Harms TA; Hauser P
    Psychiatr Serv; 2006 Mar; 57(3):403-6. PubMed ID: 16525001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.